KRAS and neoplasm: Inactivating mutations in crucially tumor suppressor genes, particularly CDKN2A/p16, TP53, and SMAD4, cooperate with oncogenic K-RAS to promote aggressive PDAC tumor growth and metastasis [19,20,21,22,23,24,25,26].